Cobalamin deficiency is a common disorder in Chinese Shar Peis (Shar Peis) and is thus suspected to be hereditary. The objective of this study was to identify a genomic region or locus that cosegregates with the phenotype of cobalamin deficiency in Shar Peis. Serum cobalamin concentrations were measured, and blood for genomic DNA extraction was collected from 14 cobalamin-deficient Shar Peis and 28 Shar Peis with a serum cobalamin concentration in the reference range. The 327 microsatellite markers from the canine minimal screening set 2 and 4 additional markers were amplified by polymerase chain reaction and genotyped by automated capillary electrophoresis. Two microsatellite markers, DTR13.6 (P 5 1.4 Â 10 À6 ) and REN13N11 (P 5 1.5 Â 10 À5 ), both on canine chromosome 13, showed evidence of linkage disequilibrium. These findings indicate that the region of chromosome 13 near these markers should be mapped and closely examined for potential mutations associated with this disease in Shar Peis.
) is a water-soluble vitamin that is synthesized by microorganisms and essential for DNA, heme, and fatty acid synthesis and also for intermediate metabolism of sulfur-containing amino acids (Hall 1979; Carmel et al. 2003; Solomon 2007) . Cobalamin is absorbed via receptor-mediated endocytosis in the brush border of the ileum (Fyfe et al. 2004) . Cobalamin is then transcytosed through the intestinal epithelial cells and into the bloodstream and transported to various cells to act as a cofactor for the functions mentioned above (Fowler 1998; Kozyraki et al. 1999; Solomon 2007) . Cobalamin is involved in a variety of metabolic processes in many tissues, including cell growth (Scalabrino et al. 2000) and peripheral and central nervous system function (Scalabrino et al. 2000; Volkov et al. 2006) . Bone marrow (Fyfe et al. 1991) as well as bones (Tucker et al. 2005) are also affected by cobalamin. A variety of gastrointestinal disorders can cause cobalamin malabsorption, which will lead to depletion of cellular cobalamin stores and may result in malfunction of multiple organ systems (Volkov et al. 2006) .
Subnormal serum cobalamin concentrations have been reported anecdotally in Chinese Shar Peis (Shar Pei) (Williams 1991; Bishop et al. 2007) . Interestingly, over a 4-year period, 64.0% of serum samples from Shar Peis that were submitted to the Gastrointestinal Laboratory at Texas A&M University for the measurement of serum cobalamin concentration had serum cobalamin concentrations below the lower limit of the reference range (252-908 ng/l) (Bishop et al. 2007 ).
Furthermore, 53 of 139 (38.1%) of all submitted serum samples from Shar Peis had serum cobalamin concentrations below the detection limit of the assay (Bishop et al. 2007 ).
The authors hypothesize that in the Shar Pei, cobalamin deficiency is a genetic condition. Therefore, the aim of this study was to perform a genome wide scan using the canine minimal screening set 2 (MSS-2) to identify a locus or loci that cosegregate with cobalamin deficiency. The MSS-2 set is a group of microsatellite markers that have been used previously to identify candidate gene regions of interest in canine hereditary diseases Clark et al. 2006; Lippmann et al. 2007 ). This set of 327 markers provides an average spacing of 9 Mb throughout the canine genome (Guyon et al. 2003; Clark, Tsai, et al. 2004) . In order to evaluate linkage, linkage analysis was utilized as this approach allows for the use of small numbers of unrelated affected and unaffected individuals (Nolte and Te Meerman 2002; Nordborg and Tavare 2002; Clark et al. 2005) . This technique has previously been shown to be effective for studying genetic diseases in purebred dog populations (Hyun et al. 2003; Sutter et al. 2004; Clark et al. 2005 Clark et al. , 2006 Awano et al. 2009 ).
Materials and Methods

Sample Collection
Whole blood and serum samples were collected from 42 unrelated Shar Peis over a 4-year period, from various parts of the United States. The pedigree information was evaluated for a minimum of 3 generations whenever possible to ensure that dogs were not closely related. The protocol for collection of blood samples from Shar Peis was reviewed and approved by the Clinical Research Review Committee at Texas A&M University (CRRC No. 2007-30) . Owners were asked to complete a questionnaire, collecting information concerning their dogs, including age, sex, sexual status, health status (including current medications and vaccination status), and the history of any prior supplementation with cobalamin, either in pure form or as part of a vitamin B complex preparation. Food was withheld from the dogs for at least 12 h before collection of blood samples. Measurements of serum concentrations of cobalamin and canine trypsin-like immunoreactivity (cTLI) were performed at the Gastrointestinal Laboratory at Texas A&M University. The reference range for serum cobalamin and cTLI concentrations have previously been established as 252-908 ng/l and 5.7 À45.2 lg/l, respectively (Gastrointestinal Laboratory at Texas A&M University; http://www.cvm.tamu.edu/gilab/assays/index.shtml; accessed 9 February 2009). The concentrations of serum cobalamin were measured using an automated chemiluminescence assay (Immulite2000, Vitamin B12, Siemens Healthcare Diagnostics Inc., Deerfield, IL), and serum cTLI was measured using a radioimmunoassay (Canine TLI Double Antibody Radioimmunoassay, Siemens Healthcare Diagnostics, Deerfield, IL). The cobalamin assay has a detection limit of 150 ng/l. Dogs with a serum cobalamin concentration ,150 ng/l were considered to be severely cobalamin deficient. In order to avoid including any dogs with mild hypocobalaminemia into the control group, Shar Peis with a serum cobalamin concentration within the reference range but 400 ng/l were excluded from the control group. A Mann-Whitney test was used to compare the median of age between the 2 groups of Shar Peis. A Fisher's Exact test was used to evaluate whether gender status was associated with cobalamin deficiency. All data were tested for normal distribution using the Kolmogorov-Smirnov test. Significance was set at P , 0.05.
Genotyping
Genomic DNA was isolated from whole blood samples using a commercial kit (Puregene DNA Isolation Kit, Gentra Systems, Minneapolis, MN). Spectrophotometry was used to evaluate purity and quantity of the extracted DNA prior to further analysis. The 327 microsatellite markers of the MSS-2 were used for the genome scan. Polymerase chain reaction (PCR) primers for these markers and multiplex PCR conditions have previously been described (Clark, Tsai, et al. 2004) . PCR was performed using a Mastercycler (Eppendorf North America, Westbury, NY), and the PCR products were analyzed by capillary gel electrophoresis on a genetic analyzer (ABI Prism 3130x Sequencer, Applied Biosystem, Foster City, CA), with an internal size standard (GeneScan 500 LIZ, Applied Biosystem, Foster City, CA) as previously described (Clark, Tsai, et al. 2004) . Standard fragment analysis software (Genemapper 3.5 software, Applied Biosystem) was used to evaluate the data. The genotyping results were compared with published repeats (Clark, Tsai, et al. 2004) . Four other stable microsatellite markers, not included in the canine MSS-2 (REN65A19, RH103480, RH12645, and REN13N11), were chosen to evaluate the region around microsatellite marker DTR13.6 on chromosome 13. These additional microsatellite markers had their forward primer labeled with a fluorescent dye (6-FAM, Gene Technologies Lab, College Station, TX) and were amplified and genotyped in all 42 enrolled Shar Peis. Information regarding the canine genome was obtained from the CanFam2.0 assembly (http://www.ncbi.nlm.nih.gov/genome/guide/dog/index. html; accessed 9 February 2009).
Linkage Studies
For each microsatellite marker, the most frequent allele in the group of Shar Peis with an undetectable serum cobalamin concentration was identified and was compared with the frequency in Shar Peis with a serum cobalamin concentration above 400 ng/l. A Fisher's Exact test was used to evaluate the significance of the association between the 2 variables in a 2 Â 2 contingency table format for single microsatellite markers. Evidence of genetic association was defined as P , 1.6 Â 10 À4 using Bonferroni's correction for multiple comparisons. The polymorphism information content (PIC) value, which can range from 0.0 (not informative) to 1.0 (very informative), was used to determine how informative each of the markers was for the association studies (Clark, Famula, et al. 2004) . For the microsatellite markers that were not part of the canine MSS-2, the PIC was calculated from the estimated allelic frequencies in different dog breeds (Leopoldino and Pena 2003; Clark, Famula, et al. 2004 ). The PIC value, which can range from 0 (not informative) to 1 (very informative), is a measure of heterozygosity and therefore, represents a parameter to describe the informativeness of a marker used for association studies (Clark, Famula, et al. 2004) . After the initial genome scan was performed, samples from an additional 7 Shar Peis were collected. The genotype data for these 7 dogs were analyzed only for the 2 microsatellite markers of interest (DTR13.6 and REN13N11).
Results
Serum cobalamin concentrations were measured in 42 unrelated Shar Peis. Undetectable serum cobalamin concentrations (,150 ng/l) were found in 14 of these 42 dogs (33.3%), and these 14 dogs were considered to be severely cobalamin deficient. Serum cobalamin concentrations in the remaining 28 Shar Peis ranged from 400 to 958 ng/l (median: 608 ng/l). The median age of cobalamin-deficient Shar Peis was 7.0 years (range: 2-10 years). The median age of the enrolled Shar Peis with serum cobalamin concentrations in the reference range was 4.5 years (range: 2-12 years). There was a statistically significant difference between the median age of the 2 groups (P 5 0.0191). The gender distribution of the cobalamin-deficient Shar Peis was 6 male and 8 female dogs. Thirteen of the enrolled Shar Peis with normal serum cobalamin concentrations were male and 15 were female. There was no significant association of sex and cobalamin deficiency (P 5 1.000). Serum concentrations for cTLI in cobalamin-deficient Shar Peis enrolled were all within the reference range (5.7-45.2 lg/l). A cTLI concentration within the reference range rules out exocrine pancreatic insufficiency (EPI) in the dog. This was important as EPI has been documented to be a potential cause of cobalamin deficiency (Cooper and Rosenblatt 1987; Simpson et al. 1989) .
Three hundred and thirteen microsatellite markers of the canine MSS-2 were genotyped across all 38 autosomes and sex chromosomes in all 42 dogs (14 Shar Peis with an undetectable serum cobalamin concentration and 28 Shar Peis of the control group with a serum cobalamin concentration within the reference range). Eight markers of the canine MSS-2 could not be amplified. Additionally, 6 markers of the canine MSS-2 could not be consistently genotyped. The amplicons of those 6 microsatellite markers showed a broad peak spectrum with nondistinct allele values.
After the genome wide scan with the canine MSS-2, only the microsatellite marker DTR13.6, located at position 28,175,350-28,175,702 on canine chromosome 13, yielded significant results (Figure 1 ). PCR product sizes of 340, 341, 352, and 356 bp were observed. Allele 356 bp of this microsatellite marker was seen significantly more frequently in Shar Peis with undetectable serum cobalamin concentrations (19 of 28 alleles, 67.9%) than in the Shar Peis of the control group (8 of 56 alleles, 14.3%; Table 1 ). The genotyped alleles of the microsatellite marker DTR13.6 are shown in Table 2 . A Fisher's Exact test as a single analysis method and the Bonferroni correction indicated an association for allele 356 bp of DTR13.6 with cobalamin deficiency in Shar Peis (P 5 1.4 Â 10 À6 ). Four other stable microsatellite markers, that are not included in the canine MSS-2, were chosen to evaluate the region around microsatellite marker DTR13.6. The canine microsatellite markers REN65A19, RH103480, RH12645, and REN13N11 are all located in close proximity to microsatellite marker DTR13.6 on chromosome 13 (Figure 2 ). Of these, REN65A19, RH103480, and RH12645, revealed no association with cobalamin deficiency in Shar Peis (P 5 8.5 Â 10 À2 , 1.8 Â 10 À1 , and 1.5 Â 10 À1 , respectively) based on a Fisher's Exact test with a Bonferroni correction for multiple comparisons. However, allele 315 bp of microsatellite marker REN13N11, which is located at position 29,189,076-29,189,385 showed a significant association with cobalamin deficiency (P 5 1.5 Â 10 À5 ) using a Fisher's Exact test and Bonferroni's correction for multiple comparisons. In fact, 18 of 28 (64.3%) cobalamin-deficient Shar Pei chromosomes carried this allele compared with only 9 of 56 Shar Peis of the control group (16.1%; Table 1 ). The genotyped alleles of the microsatellite marker REN13N11 are shown in Table 2 . In addition, the P value for genetic disequilibrium of both microsatellite markers DTR13.6 and REN13N11 was computed. An adjusted P value of 0.01 revealed that these 2 markers form a single haplotype.
To the author's knowledge, there are no previously published reports regarding microsatellite marker REN13N11 in different dog breeds. Consequently, the characteristics of this canine microsatellite marker and the frequency of occurrence of different alleles were evaluated (Table 3 ). The PIC value for the canine microsatellite marker REN13N11, calculated based on the alleles obtained for the different dog breeds, was 0.79 (Leopoldino and Pena 2003; Clark, Famula, et al. 2004 ). Being relatively close to a value of 1.0, this PIC value indicates a sufficient polymorphism of the microsatellite marker REN13N11 and thus the usefulness of its interpretation in this association study.
A pedigree of a Shar Pei family was investigated with their respective cobalamin concentrations and the contributions of the significant allele 356 of microsatellite marker DTR13.6 and the significant allele 315 of the microsatellite marker REN13N11. We could only obtain samples from the sire, dam, and 2 puppies from one of their litters. The male puppy was diagnosed with cobalamin deficiency and was homozygous for both significant alleles of the respective microsatellite markers, whereas the female puppy had a normal serum cobalamin concentration and was homozygous for a different allele. The 2 unaffected Shar Pei parents were both heterozygous with one significant allele present (Figure 3 ). The result of this analysis would suggest that the cobalamin deficiency in those few Shar Peis may follow an autosomal recessive trait.
After completion of the genome scan with the 42 Shar Peis, 7 additional Shar Peis (4 cobalamin deficient and 3 with a cobalamin concentration of the control group) were genotyped for the 2 microsatellite markers of interest, leading to a further decreased P value for both DTR13.6 and REN13N11 (7.8 Â 10 À7 and 2.09 Â 10 À6 , respectively).
Discussion
Inherited disorders of cobalamin metabolism in humans may affect absorption, transport, or cellular uptake of cobalamin (Fowler 1998) . Humans with juvenile cobalamin deficiency were found to have a mutation of the gene encoding intrinsic factor (Tanner et al. 2005 ). Another group of human patients showed mutations of the cubilin and amnionless genes, leading to Imerslund-Gräsbeck syndrome (Hauck et al. 2008) . These 2 genes code for proteins that form the cubam receptor, which is located on the brush border membrane of the ileal epithelial cells, and they are jointly responsible for endocytosis of the intrinsic factor-cobalamin complexes (Kozyraki et al. 1999; Fyfe et al. 2004) . The various effects of cobalamin deficiency are ultimately due to deficient action of the 2 main cobalaminrequiring enzymes, methylmalonyl-CoA mutase and methionine synthase (Fowler 1998) . In dogs, a selective intestinal cobalamin malabsorption has been reported in a family of Giant Schnauzers (Fyfe et al. 1991) . This syndrome is similar to ImerslundGräsbeck syndrome (He et al. 2003) . Affected puppies show clinical signs between 6 and 12 weeks of age, including neutropenia with hypersegmentation, anemia with anisocytosis, poikilocytosis, and megaloblastic changes of the bone marrow (Fyfe et al. 1991 ). There has also been a case report of anemia due to cobalamin deficiency in a Border collie (Morgan and McConnell 1999; Battersby et al. 2005) . The dog was found to have erythroblastic anemia and methylmalonic aciduria. Additionally, juvenile selective cobalamin malabsorption in Australian Shepherds and Beagles has been reported (Fordyce et al. 2000; Battersby et al. 2005) . These dogs presented with clinical signs of hyperammonemia in one report and hypoglycemia associated with vomiting, diarrhea, and seizure activity in another (Fordyce et al. 2000; Battersby et al. 2005) .
Shar Peis with cobalamin deficiency often present with clinical signs of chronic gastrointestinal disease (usually small bowel diarrhea and weight loss), frequently with gastrointestinal protein loss. However, this syndrome has not yet been extensively characterized in this breed. Unfortunately, all evidence is purely anecdotal (Williams 1991; Peterson and Willard 2003; Bishop et al. 2007 ). Cobalamin deficiency in Shar Peis appears to differ from other cobalamin deficiency syndromes reported in dogs (Fyfe et al. 1991; Fordyce et al. 2000) and humans (Carmel 2000) where gastrointestinal symptoms have not been described. The lack of the classical signs of cobalamin deficiency (Fyfe et al. 1991; Carmel 2000; Fordyce et al. 2000) suggests that other mechanisms may be responsible for this condition in Shar Peis, such as malabsorption interference or defective transport of cobalamin, and a slowonset of cobalamin deficiency may lead to a clinical syndrome causing gastrointestinal disease.
The success of linkage studies is crucially dependent on correct assignment of phenotypes. In order to prevent false classification of affected dogs, dogs with serum cobalamin concentrations in the lower range of the reference range ( 400 ng/l) and dogs younger than 2 years of age were excluded from the control group. This was done because cobalamin deficiency has been mostly characterized in juvenile dogs (Fyfe et al. 1991; Fordyce et al. 2000; Battersby et al. 2005) , and clinical experience (Williams 1991; Peterson and Willard 2003; Bishop et al. 2007) suggests that Shar Peis usually do not develop cobalamin deficiency until later on in life. Thus, our goal was to exclude any dogs with potentially subclinical or preclinical cobalamin deficiency from the control group. This exclusion of young dogs may also explain the discrepancy in ages between the 2 groups. Furthermore, data collected from the questionnaires regarding the current health status for each dog also suggested that control dogs (.400 ng/l) enrolled into this study were clinically healthy, which provides evidence that cobalamin deficiency in this breed is mainly manifested in association with gastrointestinal disease.
The linkage analysis approach uses a nonrandom association of alleles, which allows for the use of smaller numbers of affected and unaffected individuals (Nolte and Te Meerman 2002; Nordborg and Tavare 2002) . Several veterinary studies have shown that even small sample sizes are useful for studying genetic diseases in purebred dog populations (Hyun et al. 2003; Clark et al. 2006; Lippmann et al. 2007; Awano et al. 2009 ). As a first step, a genome wide scan can be performed using a relatively small number of markers in order to identify regions of association (Sutter et al. 2004 ) and such an approach has been conducted in this study. However, an association is dependent on the respective population, and linkage disequilibrium can extend from 400 to 700 kb in popular breeds (e.g., GSD, Labrador Figure 3 . Pedigree of a Shar Pei family. This figure shows a pedigree of a sire and dam and 2 puppies from one of their litters, characterizing the contributions of the significant allele 356 of microsatellite marker DTR13.6 (A) and the significant allele 315 of microsatellite marker REN13N11 (B). The allele combination for both littermates being homozygous for both significant alleles is shown (female: normal serum cobalamin concentration and male: cobalamin deficient). The 2 unaffected Shar Pei parents present with only one of the significant alleles each.
Retriever), whereas it can range from 3 to 3.2 Mb in breeds with a smaller population size such as the Chinese Shar Pei (Guyon et al. 2003; Sutter et al. 2004 ). In the United States for instance, Shar Peis appear to be a rare breed, ranked 45th by the American Kennel Club in 2008 (compared with position 3 for the GSD). Therefore, in Shar Peis a potentially affected genomic locus, such as a mutant gene, could potentially be identified using the MSS-2 set and may be located up to 3 Mb up-or down-stream of the respective microsatellite marker.
However, this study may not conclusively narrow down the region on chromosome 13 as the major locus or primary gene responsible for cobalamin deficiency in the Shar Pei because the MSS-2 set contains only 327 microsatellite markers with an average marker spacing of 9 Mb, and thus large gaps may be missed. However, not all genes that have been associated with cobalamin deficiency in humans or genes encoding for cobalamin-binding proteins have been identified in the dog (Qureshi et al. 1994; Tanner et al. 2005) . Therefore, further studies to fine map this region as well as the whole genome using a single nucleotide polymorphism (SNP) array are warranted.
Allele 356 bp of microsatellite marker DTR13.6, which is part of the canine MSS-2, was found significantly more frequently in cobalamin-deficient Shar Peis than in Shar Peis of the control group. This marker is well characterized in other dog breeds, such as the Boykin Spaniel, German Shepherd dog, Shetland Sheepdog, Great Dane, Collie, and Havanese. The published PIC for the microsatellite marker DTR13.6 is 0.65 (Clark, Tsai, et al. 2004 ). The PCR product size for this marker ranged from 316 to 356 bp (316, 336, 340, 344, 348, 352, and 356, respectively) (Clark, Tsai, et al. 2004) . We also found an additional canine microsatellite marker (REN13N11) that is not included in the canine MSS-2, whose allele 315 bp was also significantly associated with cobalamin deficiency in Shar Peis. Microsatellite marker REN13N11 was evaluated for PCR product size and PIC value. The PIC describes the usefulness of genetic markers for linkage studies when attempting to localize the gene locus on the chromosome, which may be involved in a rare disease (Guo and Elston 1999) . Because the PIC values for both canine microsatellite markers that appeared to be associated with cobalamin deficiency in Shar Peis, DTR13.6 and REN13N11, were similar, both markers are equally informative.
In this study, we present the first evidence of an association in a region located on canine chromosome 13. In this region, there are no previously identified genes reported to be associated with cobalamin deficiency in dogs or any other species. According to the data that is publicly available on the Ensemble Genome Browser, only one gene was identified near the region of the 2 microsatellite markers on canine chromosome 13. This gene, MYC_CANFA, is located between the 2 microsatellite markers that showed linkage disequilibrium, which is located approximately 0.06 Mb from microsatellite marker DTR13.6 and 1.01 Mb from REN12N11. Regec et al. (1995) have shown that the human transcobalamin II gene contains at least one binding motif for transacting oncogene products such as c-myc protein, the product of the MYC_CANFA gene. Hence, further investigation is warranted to determine whether the MYC_CANFA gene represents a potential candidate gene for cobalamin deficiency in Shar Peis.
In summary, we present evidence for an association of canine microsatellite markers DTR13.6 and REN13N11, located on chromosome 13, with cobalamin deficiency in Chinese Shar Peis. The future aim is to utilize a finer mapping tool, such as SNPs, to both verify and fine map this region that is associated with this syndrome in the Shar Pei to locate candidate genes for further investigation.
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